Post-earnings recap
Reported
Wed, Mar 7, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a loss per share of $0.54, which was below expectations. The stock reacted negatively, dropping 4.08%, likely due to the disappointing earnings report. Investors may be concerned about the company's financial performance and future outlook without any guidance provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.54 | N/A | -6.51% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.